<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337879</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Superficial Vein Thrombosis in an Asymptomatic Case of Cholangiocarcinoma with Recent History of COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1095</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14091095</ELocationID><Abstract><AbstractText>The COVID-19 pandemic brought into prominence several emergent medical and surgical entities, but, also, it served as trigger and contributor for numerous apparently unrelated ailments such as arterial and venous thromboembolic complications. Additional risk factors for these thrombotic traits may be concurrent (known or unknown) malignancies, including at hepatic level. Among these, cholangiocarcinoma (CCA), a rare cancer of intra- and extra-hepatic biliary ducts, represents a very aggressive condition that typically associates local and distant advanced stages on first presentation requiring a prompt diagnosis and a stratified management. This neoplasia has been reported to present a large spectrum of paraneoplastic syndromes in terms of dermatologic, renal, systemic, neurologic, endocrine, and cardiovascular settings, that, overall, are exceptional in their epidemiologic impact when compared to other cancers. Our aim was to introduce a most unusual case of CCA-associated distant thrombosis in a male adult who initially was considered to experience COVID-19-related thrombotic features while having a history of obesity and bariatric surgery. This is a hybrid type of paper: this clinical vignette is accompanied by two distinct sample-focused analyses as a basis for discussion; they each had different methods depending on their current level of statistical evidence. We only included English-published articles in PubMed, as follows: Firstly, we conducted a search of reports similar to the present case, regarding distant vein thrombosis in CCA, from inception until the present time. We performed a literature search using the keywords "cholangiocarcinoma", "thrombosis", and "Trousseau's syndrome" and identified 20 cases across 19 original papers; hence, the current level of evidence remains very low Secondly, we searched for the highest level of statistical evidence concerning the diagnosis of venous thrombosis/thromboembolism in patients who underwent COVID-19 infection (key search terms were "COVID-19", alternatively, "coronavirus", and "SARS-CoV-2", and "thrombosis", alternatively, "thromboembolism") and included the most recent systematic reviews and meta-analyses that were published in 2024 (from 1 January 2024 until 8 July 2024). After excluding data on vaccination against coronavirus or long COVID-19 syndrome, we identified six such articles. To conclude, we presented a probably unique case of malignancy with an initial manifestation consisting of recurrent superficial vein thrombosis under anticoagulation therapy, with no gastrointestinal manifestations, in a patient with a notable history for multiple episodes of SARS-CoV-2 infection and a prior endocrine (gastric) surgery. To our knowledge, this is the first identification of a CCA under these specific circumstances.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ciobica</LastName><ForeName>Mihai-Lucian</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0009-0006-4402-7194</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine I and Rheumatology, "Dr. Carol Davila" Central Military University Emergency Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandulescu</LastName><ForeName>Bianca-Andreea</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine I and Rheumatology, "Dr. Carol Davila" Central Military University Emergency Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PhD Doctoral School of "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotcan</LastName><ForeName>Mihai Alexandru</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Haematology, "Dr. Carol Davila" Central Military University Emergency Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumitrescu</LastName><ForeName>Lucian-Marius-Florin</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Pathology, "Dr. Carol Davila" Central Military University Emergency Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eftimie</LastName><ForeName>Lucian-George</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Pathology, "Dr. Carol Davila" Central Military University Emergency Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Anatomy and Biomechanics, National University of Physical Education and Sports, 060057 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calin</LastName><ForeName>Cezar-Ionut</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>Department of Oncology, "Dr. Carol Davila" Central Military University Emergency Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iordache</LastName><ForeName>Mihaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1st Internal Medicine Department, "Dr. Carol Davila" Central Military University Emergency Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuzino</LastName><ForeName>Dragos</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Radiology and Medical Imaging II, "Dr. Carol Davila" Central Military University Emergency Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Oncology, and Haematology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carsote</LastName><ForeName>Mara</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8585-3835</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Endocrinology V, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nistor</LastName><ForeName>Claudiu</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2274-5666</Identifier><AffiliationInfo><Affiliation>Department 4-Cardio-Thoracic Pathology, Thoracic Surgery II Discipline, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Thoracic Surgery Department, "Dr. Carol Davila" Central Emergency University Military Hospital, 010825 Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radu</LastName><ForeName>Ana-Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Gastroenterology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">biopsy</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">cholangiocarcinoma</Keyword><Keyword MajorTopicYN="N">endocrine surgery</Keyword><Keyword MajorTopicYN="N">liver</Keyword><Keyword MajorTopicYN="N">paraneoplastic syndrome</Keyword><Keyword MajorTopicYN="N">surgery</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword><Keyword MajorTopicYN="N">tumour</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337879</ArticleId><ArticleId IdType="pmc">PMC11433426</ArticleId><ArticleId IdType="doi">10.3390/life14091095</ArticleId><ArticleId IdType="pii">life14091095</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Romero Starke K., Kaboth P., Rath N., Reissig D., Kaempf D., Nienhaus A., Seidler A. Cardiovascular disease risk after a SARS-CoV-2 infection: A systematic review and meta-analysis. J. Infect. 2024;89:106215. doi: 10.1016/j.jinf.2024.106215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2024.106215</ArticleId><ArticleId IdType="pubmed">38971381</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael A., Hale J.T., Notta S., Haddadin T., Jbara M.H. COVID-19 Infection and ST-Elevation Myocardial Infarction: Lessons in Disease Management During a Pandemic. Cureus. 2024;16:e62008. doi: 10.7759/cureus.62008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.62008</ArticleId><ArticleId IdType="pmc">PMC11233153</ArticleId><ArticleId IdType="pubmed">38984012</ArticleId></ArticleIdList></Reference><Reference><Citation>Nistor C.E., Pantile D., Gavan C.S., Ciuche A. Pneumothorax on COVID-19 patients-retrospective clinical observations. Rom. J. Leg. Med. 2022;30:112&#x2013;116. doi: 10.4323/rjlm.2022.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.4323/rjlm.2022.112</ArticleId></ArticleIdList></Reference><Reference><Citation>Obeagu E.I., Obeagu G.U. Thromboinflammation in COVID-19: Unraveling the interplay of coagulation and inflammation. Medicine. 2024;103:e38922. doi: 10.1097/MD.0000000000038922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000038922</ArticleId><ArticleId IdType="pmc">PMC11245273</ArticleId><ArticleId IdType="pubmed">38996158</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoshnegah Z., Siyadat P., Rostami M., Sheikhi M., Ghorbani M., Mansouritorghabeh H. Protein C and S activities in COVID-19: A systematic review and meta-analysis. J. Thromb. Thrombolysis. 2024;57:1018&#x2013;1030. doi: 10.1007/s11239-024-02971-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-024-02971-6</ArticleId><ArticleId IdType="pubmed">38722521</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Ho P., Nandurkar H., Lim H.Y. Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases. J. Thromb. Thrombolysis. 2024;57:852&#x2013;864. doi: 10.1007/s11239-024-02975-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-024-02975-2</ArticleId><ArticleId IdType="pubmed">38649560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt B.J., Kuehn R., Fox T., Carson A., Scandrett K., Davey Smith G., Garner P. Challenging the current hypothesis that thrombosis is responsible for the post-COVID-19 condition. Res. Pract. Thromb. Haemost. 2024;8:102442. doi: 10.1016/j.rpth.2024.102442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rpth.2024.102442</ArticleId><ArticleId IdType="pmc">PMC11186963</ArticleId><ArticleId IdType="pubmed">38903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S., Kenney D., Jayaraman A., O&#x2019;Connell A.K., Walachowski S., Montanaro P., Reinhardt C., Colucci G., Crossland N.A., Douam F., et al. Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection. Front. Immunol. 2024;15:1397990. doi: 10.3389/fimmu.2024.1397990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1397990</ArticleId><ArticleId IdType="pmc">PMC11190167</ArticleId><ArticleId IdType="pubmed">38911865</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Perry A., Sanchez Parra C., Gonzalez Torriente A., Ghumman H., Charkowick S., Colon J., Heide M., Jaglal M., Mhaskar R., et al. Incidence of Thrombosis in COVID-19 Patients Compared to Non-COVID-19 Sepsis Patients in the Intensive Care Unit. J. Clin. Med. 2024;13:2974. doi: 10.3390/jcm13102974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13102974</ArticleId><ArticleId IdType="pmc">PMC11121895</ArticleId><ArticleId IdType="pubmed">38792515</ArticleId></ArticleIdList></Reference><Reference><Citation>Othman H.Y., Zaki I.A.H., Isa M.R., Ming L.C., Zulkifly H.H. A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients. BMC Infect. Dis. 2024;24:484. doi: 10.1186/s12879-024-09374-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09374-1</ArticleId><ArticleId IdType="pmc">PMC11088167</ArticleId><ArticleId IdType="pubmed">38730292</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis S., Faske A., Monsef I., Langer F., M&#xfc;ller O.J., Kranke P., Meybohm P., Weibel S. Anticoagulation in COVID-19 patients&#x2014;An updated systematic review and meta-analysis. Thromb. Res. 2024;238:141&#x2013;150. doi: 10.1016/j.thromres.2024.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2024.04.007</ArticleId><ArticleId IdType="pubmed">38718472</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang C.H., Ahmed O., Liu W., See X.Y., Chang Y.C., Peng C.Y., Wang Z., Chiang C.H., Hsia Y.P., Chiang C.H. Thromboprophylaxis for outpatients with COVID-19: A Systematic Review and Meta-analysis. Thromb. Thrombolysis. 2024;57:784&#x2013;787. doi: 10.1007/s11239-024-02966-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-024-02966-3</ArticleId><ArticleId IdType="pubmed">38671166</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S., Arnold D.M., Bradbury C.A., Broxmeyer L., Connors J.M., Falanga A., Iba T., Kaatz S., Levy J.H., Middeldorp S., et al. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. J. Thromb. Haemost. 2024;22:1779&#x2013;1797. doi: 10.1016/j.jtha.2024.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2024.02.011</ArticleId><ArticleId IdType="pubmed">38503600</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmanaban V., Ruff S.M., Pawlik T.M. Multi-Disciplinary Care of Hilar Cholangiocarcinoma: Review of Guidelines and Recent Advancements. Cancers. 2023;16:30. doi: 10.3390/cancers16010030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers16010030</ArticleId><ArticleId IdType="pmc">PMC10778096</ArticleId><ArticleId IdType="pubmed">38201457</ArticleId></ArticleIdList></Reference><Reference><Citation>Bath N.M., Pawlik T.M. Narrative review: Current management and novel targeted therapies in intrahepatic cholangiocarcinoma. Chin. Clin. Oncol. 2023;12:5. doi: 10.21037/cco-22-109.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cco-22-109</ArticleId><ArticleId IdType="pubmed">36922354</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaresima S., Melandro F., Giovanardi F., Shah K., De Peppo V., Mennini G., Ghinolfi D., Limkemann A., Pawlik T.M., Lai Q. New Insights in the Setting of Transplant Oncology. Medicina. 2023;59:568. doi: 10.3390/medicina59030568.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59030568</ArticleId><ArticleId IdType="pmc">PMC10058845</ArticleId><ArticleId IdType="pubmed">36984569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu R., Sharma P., Kumar A. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment. J. Gastrointest. Cancer. 2023;54:213&#x2013;226. doi: 10.1007/s12029-021-00728-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12029-021-00728-5</ArticleId><ArticleId IdType="pubmed">35023010</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S.U., Sana M.K., Tahir Z., Ali A., Shah P.A. Paraneoplastic syndromes in cholangiocarcinoma. World J. Hepatol. 2020;12:897&#x2013;907. doi: 10.4254/wjh.v12.i11.897.</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v12.i11.897</ArticleId><ArticleId IdType="pmc">PMC7701960</ArticleId><ArticleId IdType="pubmed">33312417</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsote M., Valea A., Dumitru N., Terzea D., Petrova E., Albu S., Buruiana A., Ghemigian A. Metastases in daily endocrine practice. Arch. Balk. Med. Union. 2016;51:476&#x2013;480.</Citation></Reference><Reference><Citation>Chen J.X., Xu L.L., Cheng J.P., Xu X.H. Challenging anticoagulation therapy for multiple primary malignant tumors combined with thrombosis: A case report and review of literature. World J. Clin. Cases. 2024;12:1704&#x2013;1711. doi: 10.12998/wjcc.v12.i9.1704.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v12.i9.1704</ArticleId><ArticleId IdType="pmc">PMC10989423</ArticleId><ArticleId IdType="pubmed">38576733</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ardes D., Boccatonda A., Cocco G., Fabiani S., Rossi I., Bucci M., Guagnano M.T., Schiavone C., Cipollone F. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship. World J. Gastroenterol. 2022;28:1102&#x2013;1112. doi: 10.3748/wjg.v28.i11.1102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i11.1102</ArticleId><ArticleId IdType="pmc">PMC8985482</ArticleId><ArticleId IdType="pubmed">35431501</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramowitz B.R., Coles M., Aytaman A., Chander-Roland B., DiLeo D.A. Simultaneous portal vein thrombosis and splenic vein thrombosis in a COVID-19 patient: A case report and review of literature. World J. Clin. Cases. 2024;12:3561&#x2013;3566. doi: 10.12998/wjcc.v12.i18.3561.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v12.i18.3561</ArticleId><ArticleId IdType="pmc">PMC11229906</ArticleId><ArticleId IdType="pubmed">38983408</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdary P. COVID-19 coagulopathy&#x2014;What should we treat? Exp. Physiol. 2022;107:749&#x2013;758. doi: 10.1113/EP089404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089404</ArticleId><ArticleId IdType="pmc">PMC9328279</ArticleId><ArticleId IdType="pubmed">35733235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi R., Nasri F., Kalantari T. Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers. Ann. Hematol. 2024;103:1819&#x2013;1831. doi: 10.1007/s00277-024-05630-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-024-05630-1</ArticleId><ArticleId IdType="pubmed">38349409</ArticleId></ArticleIdList></Reference><Reference><Citation>He S., Blomb&#xe4;ck M., Wall&#xe9;n H. COVID-19: Not a thrombotic disease but a thromboinflammatory disease. Ups. J. Med. Sci. 2024;129 doi: 10.48101/ujms.v129.9863.</Citation><ArticleIdList><ArticleId IdType="doi">10.48101/ujms.v129.9863</ArticleId><ArticleId IdType="pmc">PMC10845889</ArticleId><ArticleId IdType="pubmed">38327640</ArticleId></ArticleIdList></Reference><Reference><Citation>Nistor C., Ciuche A., Constantinescu I. Emergency surgical tracheal decompression in a huge retrosternal goiter. Acta Endocrinol. 2017;13:370&#x2013;374. doi: 10.4183/aeb.2017.370.</Citation><ArticleIdList><ArticleId IdType="doi">10.4183/aeb.2017.370</ArticleId><ArticleId IdType="pmc">PMC6516576</ArticleId><ArticleId IdType="pubmed">31149202</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinga M., Jurcu&#x163; C., Vasilescu F., Becheanu G., Stancu S.H., Ciobaca L., Mircescu G., Jinga V. A rare case of digestive hemorrhage in an elderly patient: Diagnosis and treatment difficulties. Rom. J. Morphol. Embryol. 2012;53((Suppl. S3)):831&#x2013;834.</Citation><ArticleIdList><ArticleId IdType="pubmed">23188449</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia I., Lumpuy-Castillo J., Magalhaes G., S&#xe1;nchez-Ferrer C.F., Lorenzo &#xd3;., Peir&#xf3; C. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: A link with diabetes mellitus. Cardiovasc. Diabetol. 2024;23:75. doi: 10.1186/s12933-023-02097-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-02097-8</ArticleId><ArticleId IdType="pmc">PMC10880237</ArticleId><ArticleId IdType="pubmed">38378550</ArticleId></ArticleIdList></Reference><Reference><Citation>Samy A.M., Kandeil M.A., Sabry D., Abdel-Ghany A.A., Mahmoud M.O. From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences. Heliyon. 2024;10:e30387. doi: 10.1016/j.heliyon.2024.e30387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2024.e30387</ArticleId><ArticleId IdType="pmc">PMC11088336</ArticleId><ArticleId IdType="pubmed">38737288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zenoaga-Barb&#x103;ro&#x219;ie C., Berca L., Vassu-Dimov T., Toma M., Nica M.I., Alexiu-Toma O.A., Ciornei C., Albu A., Nica S., Nistor C., et al. The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome. Balkan J. Med. Genet. 2023;26:21&#x2013;26. doi: 10.2478/bjmg-2023-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/bjmg-2023-0003</ArticleId><ArticleId IdType="pmc">PMC10413885</ArticleId><ArticleId IdType="pubmed">37576792</ArticleId></ArticleIdList></Reference><Reference><Citation>Pati S., Irfan W., Jameel A., Ahmed S., Shahid R.K. Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers. 2023;15:485. doi: 10.3390/cancers15020485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15020485</ArticleId><ArticleId IdType="pmc">PMC9857053</ArticleId><ArticleId IdType="pubmed">36672434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauby-Secretan B., Scoccianti C., Loomis D., Grosse Y., Bianchini F., Straif K., International Agency for Research on Cancer Handbook Working Group Body Fatness and Cancer--Viewpoint of the IARC Working Group. N. Engl. J. Med. 2016;375:794&#x2013;798. doi: 10.1056/NEJMsr1606602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr1606602</ArticleId><ArticleId IdType="pmc">PMC6754861</ArticleId><ArticleId IdType="pubmed">27557308</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson R.B., Lathigara D., Kaushal D. Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk. Int. J. Mol. Sci. 2023;24:6192. doi: 10.3390/ijms24076192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076192</ArticleId><ArticleId IdType="pmc">PMC10094585</ArticleId><ArticleId IdType="pubmed">37047163</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauer D.P. What is currently known about the association between bariatric surgery and cancer. Surg. Obes. Relat. Dis. 2023;19:530&#x2013;533. doi: 10.1016/j.soard.2023.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soard.2023.01.028</ArticleId><ArticleId IdType="pubmed">36959026</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminian A., Wilson R., Al-Kurd A., Tu C., Milinovich A., Kroh M., Rosenthal R.J., Brethauer S.A., Schauer P.R., Kattan M.W., et al. Association of Bariatric Surgery with Cancer Risk and Mortality in Adults with Obesity. JAMA. 2022;327:2423&#x2013;2433. doi: 10.1001/jama.2022.9009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.9009</ArticleId><ArticleId IdType="pmc">PMC9166218</ArticleId><ArticleId IdType="pubmed">35657620</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams T.D., Meeks H., Fraser A., Davidson L.E., Holmen J., Newman M., Ibele A.R., Playdon M., Hardikar S., Richards N., et al. Long-term cancer outcomes after bariatric surgery. Obesity. 2023;31:2386&#x2013;2397. doi: 10.1002/oby.23812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.23812</ArticleId><ArticleId IdType="pmc">PMC10449359</ArticleId><ArticleId IdType="pubmed">37605634</ArticleId></ArticleIdList></Reference><Reference><Citation>Njei B., McCarty T.R., Sharma P., Lange A., Najafian N., Ngu J.N., Ngomba V.E., Echouffo-Tcheugui J.B. Bariatric Surgery and Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Obes. Surg. 2018;28:3880&#x2013;3889. doi: 10.1007/s11695-018-3431-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-018-3431-5</ArticleId><ArticleId IdType="pmc">PMC6219901</ArticleId><ArticleId IdType="pubmed">30069863</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid S.I., Maasarani S., Wiegmann J., Wiegmann A.L., Becerra A.Z., Omotosho P., Torquati A. Association of Bariatric Surgery and Risk of Cancer in Patients with Morbid Obesity. Ann. Surg. 2022;275:1&#x2013;6. doi: 10.1097/SLA.0000000000005035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000005035</ArticleId><ArticleId IdType="pubmed">34183506</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari S., Sapkota N., Han Z. Effect of fasting on cancer: A narrative review of scientific evidence. Cancer Sci. 2022;113:3291&#x2013;3302. doi: 10.1111/cas.15492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.15492</ArticleId><ArticleId IdType="pmc">PMC9530862</ArticleId><ArticleId IdType="pubmed">35848874</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;&#xe7;&#xfc;k A.N., &#xc7;ift&#xe7;i S. The role of intermittent fasting and the ketogenic diet in cancer disease: Can they replace the Mediterranean diet? Eur. J. Cancer Prev. 2023;32:533&#x2013;543. doi: 10.1097/CEJ.0000000000000820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CEJ.0000000000000820</ArticleId><ArticleId IdType="pubmed">37401519</ArticleId></ArticleIdList></Reference><Reference><Citation>Klement R.J., Pazienza V. Impact of Different Types of Diet on Gut Microbiota Profiles and Cancer Prevention and Treatment. Medicina. 2019;55:84. doi: 10.3390/medicina55040084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina55040084</ArticleId><ArticleId IdType="pmc">PMC6524347</ArticleId><ArticleId IdType="pubmed">30934960</ArticleId></ArticleIdList></Reference><Reference><Citation>Psara E., Poulios E., Papadopoulou S.K., Tolia M., Vasios G.K., Giaginis C. Intermittent Fasting against Cancer Development and Progression: Highlighting Potential Anticancer Molecular Mechanisms. Anticancer Agents Med. Chem. 2023;23:1889&#x2013;1909. doi: 10.2174/1871520623666230816090229.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871520623666230816090229</ArticleId><ArticleId IdType="pubmed">37587803</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin D.W., Moon S.H., Kim J.H. Diagnosis of Cholangiocarcinoma. Diagnostics. 2023;13:233. doi: 10.3390/diagnostics13020233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13020233</ArticleId><ArticleId IdType="pmc">PMC9858255</ArticleId><ArticleId IdType="pubmed">36673043</ArticleId></ArticleIdList></Reference><Reference><Citation>Brindley P.J., Bachini M., Ilyas S.I., Khan S.A., Loukas A., Sirica A.E., Teh B.T., Wongkham S., Gores G.J. Cholangiocarcinoma. Nat. Rev. Dis. Primers. 2021;7:65. doi: 10.1038/s41572-021-00300-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00300-2</ArticleId><ArticleId IdType="pmc">PMC9246479</ArticleId><ArticleId IdType="pubmed">34504109</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorana A.A. Malignancy, thrombosis and Trousseau: The case for an eponym. J. Thromb. Haemost. 2003;1:2463&#x2013;2465. doi: 10.1111/j.1538-7836.2003.00501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2003.00501.x</ArticleId><ArticleId IdType="pubmed">14675077</ArticleId></ArticleIdList></Reference><Reference><Citation>Horsted F., West J., Grainge M.J. Risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis. PLoS Med. 2012;9:e1001275. doi: 10.1371/journal.pmed.1001275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001275</ArticleId><ArticleId IdType="pmc">PMC3409130</ArticleId><ArticleId IdType="pubmed">22859911</ArticleId></ArticleIdList></Reference><Reference><Citation>Sack G.H., Jr., Levin J., Bell W.R. Trousseau&#x2019;s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features. Medicine. 1977;56:1&#x2013;37. doi: 10.1097/00005792-197756010-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-197756010-00001</ArticleId><ArticleId IdType="pubmed">834136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ching C.K. Trousseau&#x2019;s syndrome in a patient with cholangiocarcinoma. Am. J. Gastroenterol. 1991;86:928&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pubmed">1647662</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins E.B., Fleming K.A., Garrido M.C., Hine K.R., Chapman R.W. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1994;107:537&#x2013;542. doi: 10.1016/0016-5085(94)90182-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0016-5085(94)90182-1</ArticleId><ArticleId IdType="pubmed">8039630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez J.L., Riancho J.A., Gonz&#xe1;lez-Mac&#xed;as J. Cholangiocarcinoma presenting as Trousseau&#x2019;s syndrome. Am. J. Gastroenterol. 1998;93:847&#x2013;848. doi: 10.1111/j.1572-0241.1998.847a_a.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.1998.847a_a.x</ArticleId><ArticleId IdType="pubmed">9625150</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadian S., Estcourt L. Recurrent thrombo-embolic episodes: The association of cholangiocarcinoma with antiphospholipid syndrome. Postgrad. Med. J. 1999;75:45&#x2013;46. doi: 10.1136/pgmj.75.879.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.75.879.45</ArticleId><ArticleId IdType="pmc">PMC1741098</ArticleId><ArticleId IdType="pubmed">10396590</ArticleId></ArticleIdList></Reference><Reference><Citation>Koskinas J., Betrosian A., Kafiri G., Tsolakidis G., Garaziotou V., Hadziyannis S. Combined hepatocellular-cholangiocarcinoma presented with massive pulmonary embolism. Hepatogastroenterology. 2000;47:1125&#x2013;1128.</Citation><ArticleIdList><ArticleId IdType="pubmed">11020895</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay S.K., Sarkar N., Ghosh S., Dasgupta S. Cholangiocarcinoma presenting with recurrent venous thrombosis. J. Assoc. Physicians India. 2003;51:824&#x2013;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">14651151</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasi S.H., Juan C.J., Dai M.S., Kao W.Y. Trousseau&#x2019;s syndrome related to adenocarcinoma of the colon and cholangiocarcinoma. Eur. J. Neurol. 2004;11:493&#x2013;496. doi: 10.1111/j.1468-1331.2004.00814.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2004.00814.x</ArticleId><ArticleId IdType="pubmed">15257690</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang J.W., Yeo C.D., Kim J.D., Bae S.H., Choi J.Y., Jung E.S., Rha S.E., Byun J.Y., Yoon S.K. Trousseau&#x2019;s syndrome in association with cholangiocarcinoma: Positive tests for coagulation factors and anticardiolipin antibody. J. Korean Med. Sci. 2006;21:155&#x2013;159. doi: 10.3346/jkms.2006.21.1.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2006.21.1.155</ArticleId><ArticleId IdType="pmc">PMC2733966</ArticleId><ArticleId IdType="pubmed">16479083</ArticleId></ArticleIdList></Reference><Reference><Citation>Vysetti S., Shinde S., Chaudhry S., Subramoney K. Phlegmasia cerulea dolens&#x2014;A rare, life-threatening condition. Sci. World J. 2009;9:1105&#x2013;1106. doi: 10.1100/tsw.2009.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1100/tsw.2009.123</ArticleId><ArticleId IdType="pmc">PMC5823088</ArticleId><ArticleId IdType="pubmed">19838596</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz-Ortego J., Blanco Lopez L., Carbonell Abello J., Monfort Faure J. Multiple thromboemboli associated to two occult tumors: A case mimicking catastrophic antiphospholipid syndrome. Jt. Bone Spine. 2011;78:405&#x2013;408. doi: 10.1016/j.jbspin.2011.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2011.02.014</ArticleId><ArticleId IdType="pubmed">21459648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnanapandithan K., Allaparthi S., Ukena T., Anand C. Cholangiocarcinoma: Another masquerader in the making? J. Gastrointest. Cancer. 2014;45((Suppl. S1)):14&#x2013;17. doi: 10.1007/s12029-013-9518-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12029-013-9518-2</ArticleId><ArticleId IdType="pubmed">23824629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G., Yeh J.J. Fulminant phlegmasia cerulea dolens with concurrent cholangiocarcinoma and a lupus anticoagulant: A case report and review of the literature. Blood Coagul. Fibrinolysis. 2014;25:507&#x2013;511. doi: 10.1097/MBC.0000000000000057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000057</ArticleId><ArticleId IdType="pubmed">24553060</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuri T., Kato K., Hirohara Y., Kinoshita Y., Emoto Y., Yuki M., Yoshizawa K., Tsubura A. Trousseau&#x2019;s Syndrome Caused by Intrahepatic Cholangiocarcinoma: An Autopsy Case Report and Literature Review. Case Rep. Oncol. 2014;7:376&#x2013;382. doi: 10.1159/000363689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000363689</ArticleId><ArticleId IdType="pmc">PMC4067732</ArticleId><ArticleId IdType="pubmed">24987359</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakil A., Guru P., Reddy D.R., Iyer V. Diffuse cholangiocarcinoma presenting with hepatic failure and extensive portal and mesenteric vein thrombosis. BMJ Case Rep. 2015;2015:bcr2014209171. doi: 10.1136/bcr-2014-209171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2014-209171</ArticleId><ArticleId IdType="pmc">PMC4488711</ArticleId><ArticleId IdType="pubmed">26123458</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum M.F., Ma V.Y., Betbadal A.M., Bonomo R.A., Raju R.R., Packer C.D. Trousseau&#x2019;s Syndrome in Cholangiocarcinoma: The Risk of Making the Diagnosis. Clin. Med. Res. 2016;14:53&#x2013;59. doi: 10.3121/cmr.2015.1304.</Citation><ArticleIdList><ArticleId IdType="doi">10.3121/cmr.2015.1304</ArticleId><ArticleId IdType="pmc">PMC4851453</ArticleId><ArticleId IdType="pubmed">26847482</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn T., Rudrapatna V.A., Hesse S., Sargsyan Z. Arterial Thromboses Heralding Cholangiocarcinoma. Am. J. Med. 2017;130:e341&#x2013;e342. doi: 10.1016/j.amjmed.2017.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2017.02.020</ArticleId><ArticleId IdType="pubmed">28344146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S.L., Zhang Y.S., Wei F., DeYoung L. Intrahepatic Cholangiocarcinoma Associated Paradoxical Peripheral Embolism and a Submassive Pulmonary Embolism. Ann. Vasc. Surg. 2019;61:470.e9&#x2013;470.e12. doi: 10.1016/j.avsg.2019.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2019.05.038</ArticleId><ArticleId IdType="pubmed">31394239</ArticleId></ArticleIdList></Reference><Reference><Citation>Murahashi S., Takeuchi Y., Hayashida S., Ohya Y., Shindo S., Terasaki T., Inomata Y., Hara Y. Trousseau syndrome with intrahepatic cholangiocarcinoma that could be removed radically after endovascular treatment: Report of a case. Brain Behav. 2020;10:e01660. doi: 10.1002/brb3.1660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1660</ArticleId><ArticleId IdType="pmc">PMC7375083</ArticleId><ArticleId IdType="pubmed">32506690</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki R., Ohya Y., Hayashida S., Maeda Y., Murahashi S., Kumamoto S., Tsuji A., Shibata H., Kuramoto K., Hayashi H., et al. A case of Trousseau&#x2019;s syndrome due to intrahepatic cholangiocarcinoma with an extremely high level of CA19-9. Surg. Case Rep. 2020;6:75. doi: 10.1186/s40792-020-00835-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40792-020-00835-8</ArticleId><ArticleId IdType="pmc">PMC7167392</ArticleId><ArticleId IdType="pubmed">32307602</ArticleId></ArticleIdList></Reference><Reference><Citation>Nistor C.E., Ciuche A., Cucu A.P., Serban B., Cursaru A., Cretu B., Cirstoiu C. Clavicular Malignancies: A Borderline Surgical Management. Medicina. 2022;58:910. doi: 10.3390/medicina58070910.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070910</ArticleId><ArticleId IdType="pmc">PMC9315479</ArticleId><ArticleId IdType="pubmed">35888630</ArticleId></ArticleIdList></Reference><Reference><Citation>Posch F., K&#xf6;nigsbr&#xfc;gge O., Zielinski C., Pabinger I., Ay C. Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants. Thromb. Res. 2015;136:582&#x2013;589. doi: 10.1016/j.thromres.2015.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2015.07.011</ArticleId><ArticleId IdType="pmc">PMC7311195</ArticleId><ArticleId IdType="pubmed">26210891</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.J., Harjola V.P., Huisman M.V., Humbert M., Jennings C.S., Jim&#xe9;nez D., et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Eur. Respir. J. 2019;54:1901647. doi: 10.1183/13993003.01647-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01647-2019</ArticleId><ArticleId IdType="pubmed">31473594</ArticleId></ArticleIdList></Reference><Reference><Citation>Raskob G.E., van Es N., Verhamme P., Carrier M., Di Nisio M., Garcia D., Grosso M.A., Kakkar A.K., Kovacs M.J., Mercuri M.F., et al. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N. Engl. J. Med. 2018;378:615&#x2013;624. doi: 10.1056/NEJMoa1711948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1711948</ArticleId><ArticleId IdType="pubmed">29231094</ArticleId></ArticleIdList></Reference><Reference><Citation>Young A.M., Marshall A., Thirlwall J., Chapman O., Lokare A., Hill C., Hale D., Dunn J.A., Lyman G.H., Hutchinson C., et al. Comparison of an Oral Factor Xa Inhibitor with Low Molecular Weight Heparin in Patients with Cancer with Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) J. Clin. Oncol. 2018;36:2017&#x2013;2023. doi: 10.1200/JCO.2018.78.8034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2018.78.8034</ArticleId><ArticleId IdType="pubmed">29746227</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloch M.F., Adepoju A.V., Falki V., Hajjaj M., Habet T., Habet K., Mahrosh A., Kundu S., Kataria J., Mathew M., et al. Comparative Efficacy of Oral Apixaban and Subcutaneous Low Molecular Weight Heparins in the Treatment of Cancer-Associated Thromboembolism: A Meta-Analysis. Cureus. 2023;15:e43447. doi: 10.7759/cureus.43447.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.43447</ArticleId><ArticleId IdType="pmc">PMC10498340</ArticleId><ArticleId IdType="pubmed">37711939</ArticleId></ArticleIdList></Reference><Reference><Citation>Iam-Arunthai K., Chamnanchanunt S., Thungthong P., Intalapaporn P., Nakhahes C., Suwanban T., Rojnuckarin P. Thrombosis and Bleeding Risk Scores Are Strongly Associated with Mortality in Hospitalized Patients with COVID-19: A Multicenter Cohort Study. J. Clin. Med. 2024;13:1437. doi: 10.3390/jcm13051437.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13051437</ArticleId><ArticleId IdType="pmc">PMC10932358</ArticleId><ArticleId IdType="pubmed">38592277</ArticleId></ArticleIdList></Reference><Reference><Citation>Algarni S.A., ALGhasab N.S., Alharbi M.S., Albarrak A., Alanezi A.A., Al Shehri H.M. Sex Differences and Clinical Outcomes of Patients with Coronavirus Disease 2019 Infection and Cerebral Venous Sinus Thrombosis: A Systematic Review. Clin. Appl. Thromb. Hemost. 2024;30:10760296241240748. doi: 10.1177/10760296241240748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296241240748</ArticleId><ArticleId IdType="pmc">PMC10981232</ArticleId><ArticleId IdType="pubmed">38551022</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Guo N., Zheng Q., Zhang Q., Chen J., Cai Y., Luo Q., Xu Q., Chen X., Yang S., et al. Association of interleukin-6, ferritin, and lactate dehydrogenase with venous thromboembolism in COVID-19: A systematic review and meta-analysis. BMC Infect. Dis. 2024;24:324. doi: 10.1186/s12879-024-09205-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09205-3</ArticleId><ArticleId IdType="pmc">PMC10943892</ArticleId><ArticleId IdType="pubmed">38493138</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S.S., Tao D., McMurry H.S., Shatzel J.J. Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions. Eur. J. Haematol. 2023;110:24&#x2013;31. doi: 10.1111/ejh.13874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejh.13874</ArticleId><ArticleId IdType="pmc">PMC9729376</ArticleId><ArticleId IdType="pubmed">36192850</ArticleId></ArticleIdList></Reference><Reference><Citation>Nistor C.E., G&#x103;van C.S., Ciritel A.A., Nemes A.F., Ciuche A. The Association of Minimally Invasive Surgical Approaches and Mortality in Patients with Malignant Pleuropericarditis-A 10 Year Retrospective Observational Study. Medicina. 2022;58:718. doi: 10.3390/medicina58060718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58060718</ArticleId><ArticleId IdType="pmc">PMC9229806</ArticleId><ArticleId IdType="pubmed">35743981</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier M., Lazo-Langner A., Shivakumar S., Tagalakis V., Zarychanski R., Solymoss S., Routhier N., Douketis J., Danovitch K., Lee A.Y., et al. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N. Engl. J. Med. 2015;373:697&#x2013;704. doi: 10.1056/NEJMoa1506623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1506623</ArticleId><ArticleId IdType="pubmed">26095467</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P., Bernardi E., Valle F.D., Vison&#xe0; A., Tropeano P.F., Bova C., Bucherini E., Islam M.S., Piccioli A. Extensive Computed Tomography versus Limited Screening for Detection of Occult Cancer in Unprovoked Venous Thromboembolism: A Multicenter, Controlled, Randomized Clinical Trial. Semin. Thromb. Hemost. 2016;42:884&#x2013;890. doi: 10.1055/s-0036-1592335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0036-1592335</ArticleId><ArticleId IdType="pubmed">27764880</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin P., Le Roux P.Y., Planquette B., Accassat S., Roy P.M., Couturaud F., Ghazzar N., Prevot-Bitot N., Couturier O., Delluc A., et al. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: An open-label randomised controlled trial. Lancet Oncol. 2016;17:193&#x2013;199. doi: 10.1016/S1470-2045(15)00480-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(15)00480-5</ArticleId><ArticleId IdType="pubmed">26672686</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson L., Yeoh S.E., Stansby G., Agarwal R. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE. Cochrane Database Syst. Rev. 2015:CD010837. doi: 10.1002/14651858.CD010837.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010837.pub2</ArticleId><ArticleId IdType="pubmed">25749503</ArticleId></ArticleIdList></Reference><Reference><Citation>Delluc A., Antic D., Lecumberri R., Ay C., Meyer G., Carrier M. Occult cancer screening in patients with venous thromboembolism: Guidance from the SSC of the ISTH. J. Thromb. Haemost. 2017;15:2076&#x2013;2079. doi: 10.1111/jth.13791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13791</ArticleId><ArticleId IdType="pubmed">28851126</ArticleId></ArticleIdList></Reference><Reference><Citation>Mount H.R., Rich M., Putnam M.S. Recurrent Venous Thromboembolism. Am. Fam. Physician. 2022;105:377&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">35426644</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanietzky N., Salem A.E., Elsayes K.M., Rezvani M., Palmquist S., Ahmed I., Marey A., Faria S., Gaballah A.H., Menias C.O., et al. Unusual liver tumors: Spectrum of imaging findings with pathologic correlation. Diagn. Interv. Radiol. 2024 doi: 10.4274/dir.2024.242827.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/dir.2024.242827</ArticleId><ArticleId IdType="pubmed">38856323</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J., Srinivas-Rao S., Mroueh N., Anand R., Kongboonvijit S., Sertic M., Shenoy-Bhangle A.S., Kambadakone A. Cholangiocarcinoma imaging: From diagnosis to response assessment. Abdom. Radiol. 2024;49:1699&#x2013;1715. doi: 10.1007/s00261-024-04267-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00261-024-04267-y</ArticleId><ArticleId IdType="pubmed">38578323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendiratta-Lala M., Fetzer D., Kamaya A., Parikh N.D., Singal A.G. The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance. Radiology. 2024;311:e232624. doi: 10.1148/radiol.232624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.232624</ArticleId><ArticleId IdType="pmc">PMC11140528</ArticleId><ArticleId IdType="pubmed">38742973</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang C., Sun H., Wen J., Wu X., Wu Q., Zhai D. Investigation of the relationship between COVID-19 and pancreatic cancer using bioinformatics and systems biology approaches. Medicine. 2024;103:e39057. doi: 10.1097/MD.0000000000039057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000039057</ArticleId><ArticleId IdType="pmc">PMC11296473</ArticleId><ArticleId IdType="pubmed">39093763</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf C., Mongardini F.M., Fisone F., Briatico G., Brancaccio G., Chirico F., Tolone S., Docimo L., Gambardella C., Lucido F., et al. Impact of the COVID pandemic on melanoma thickness and ulceration: A meta-analysis. Int. J. Dermatol. 2024 doi: 10.1111/ijd.17401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.17401</ArticleId><ArticleId IdType="pubmed">39095953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng H.J., Alata M.K., Nguyen Q.T., Huynh Duc Vinh P., Tan J.Y., Wong C.L. Managing and treating COVID-19 in patients with hematological malignancies: A narrative review and expert insights. Clin. Exp. Med. 2024;24:119. doi: 10.1007/s10238-024-01381-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-024-01381-5</ArticleId><ArticleId IdType="pmc">PMC11150206</ArticleId><ArticleId IdType="pubmed">38833206</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>